Ecnoglutide is a GLP-1 receptor agonist, part of a growing class of drugs that help control blood sugar and reduce hunger.

Around 220,000 Brits are expected to receive Mounjaro through the NHS over the next three years – but what are the side ...

Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure ...

What is Mounjaro, how does the weight-loss jab work and are you eligible for prescription from your GP? - From June 23, the ...

A novel weight loss drug in the same class as semaglutide has successfully met its targets in its largest clinical trial yet, ...

A common diabetes drug may be the next big thing for migraine relief. In a clinical study, obese patients with chronic ...

GLP-1 drugs such as Wegovy and Zepbound are growing increasingly prominent. But some food ingredients can also cause the body ...

If you’re considering using medication to reach a healthy body weight, your first question might be: Are weight loss drugs covered by insurance? The short answer: Sometimes, but not always.

A recent study found that older adults with diabetes who use a GLP-1 drug have double the risk of developing wet age-related ...

Compounded vs non-compounded GLP-1 RA drug products are associated with an increased risk for adverse events such as nausea and diarrhea.

A new study reports that people taking GLP-1 drugs in daily life don’t lose as much weight as those in clinical trials who ...